Carlyle to acquire Unchained Labs for $435mn
Exiting investors in the life sciences tools company are Novo Holdings A/S, Canaan Partners and TPG Biotech.
Exiting investors in the life sciences tools company are Novo Holdings A/S, Canaan Partners and TPG Biotech.